Akorn Announces Its New Board of Directors
LAKE FOREST, Ill., Oct. 28, 2020 /PRNewswire/ --Akorn, Inc. a leading specialty pharmaceutical company, today announced the appointment of its new Board of Directors. "Akorn's new shareholders have appointed a strong board of independent pharmaceutical industry and finance professionals with a mandate to steward the Company towards long-term value creation," said Robert Webster, Akorn's new Chairman. "The Company exits its reorganization process having clarified and resolved various legacy contingencies. With a significantly deleveraged balance sheet, Akorn is now positioned to resume a trajectory of growth and profits." Douglas Boothe, Akorn's President and Chief Executive Officer, commented, "I'm thrilled that Akorn's new owners have assembled such an experienced team of industry and financial experts. Akorn is poised for a bright future with talented associates, reduced debt levels, a diverse product portfolio, and a strong new board for corporate governance. I look forward to working with the new board to ensure that Akorn reaches its full potential." Akorn's new board members are:
The new board appointments follow the completion of the sale of Akorn on October 1, 2020. Akorn is now operating as a private entity under the legal name Akorn Operating Company LLC. About Akorn Akorn develops, manufactures and markets specialty pharmaceuticals, including prescription, consumer health and animal health products. As an industry leader in branded and generic products in alternate dosage forms such as ophthalmics, injectables, oral liquids, otics, topicals, inhalants and nasal sprays, we focus each day on our mission to improve lives, through the quality, availability and affordability of our products. Additional information is available on Akorn's website at www.akorn.com. Cautionary Note Regarding Forward-Looking Statements This press release includes statements that may constitute "forward-looking statements," including those regarding the Company's long-term business plan and outlook. A number of important factors could cause actual results of the Company and its subsidiaries to differ materially from those indicated by such forward-looking statements and readers should not place undue reliance on the Company's forward-looking statements. These forward-looking statements are based on information, plans and estimates at the date of this release. The Company undertakes no obligation to update any forward-looking statements to reflect changes in underlying assumptions or factors, new information, future events or other changes. Media:
View original content:http://www.prnewswire.com/news-releases/akorn-announces-its-new-board-of-directors-301162291.html SOURCE Akorn |